QQ客服 官方微博 反馈留言

	A novel series of napabucasin derivatives as orally active inhibitors of signal transducer and activator of transcription 3
	Li, Chungen; Chen, Caili; An, Qi; Yang, Tao; Sang, Zitai; Yang, Yang; Ju, Yuan; Tong, Aiping; Luo, Youfu
刊名	EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
	2019
卷号	Vol.162页码:543-554
关键词	Antitumor activity STAT3 inhibitors Napabucasin derivatives
ISSN号	0223-5234
URL标识	查看原文
公开日期	[db:dc_date_available]
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/4744131
专题	湖南大学
作者单位	1.Sichuan Univ, West China Med Sch, West China Hosp, State Key Lab Biotherapy, Chengdu 610041, Sichuan, Peoples R China 2.Sichuan Univ, West China Med Sch, West China Hosp, Ctr Canc, Chengdu 610041, Sichuan, Peoples R China 3.Collaborat Innovat Ctr Biotherapy, Chengdu 610041, Sichuan, Peoples R China
推荐引用方式 GB/T 7714	Li, Chungen,Chen, Caili,An, Qi,et al. A novel series of napabucasin derivatives as orally active inhibitors of signal transducer and activator of transcription 3[J]. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY,2019,Vol.162:543-554.
APA	Li, Chungen.,Chen, Caili.,An, Qi.,Yang, Tao.,Sang, Zitai.,...&Luo, Youfu.(2019).A novel series of napabucasin derivatives as orally active inhibitors of signal transducer and activator of transcription 3.EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY,Vol.162,543-554.
MLA	Li, Chungen,et al."A novel series of napabucasin derivatives as orally active inhibitors of signal transducer and activator of transcription 3".EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY Vol.162(2019):543-554.

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。